{
  "docId": "019de073-f021-770f-8b07-e7c119465e03",
  "docSlug": "6227ea40012eb82f352898e4936ae469",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 48 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2938006,
  "pageNumber": 6,
  "pageCount": 48,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-f021-770f-8b07-e7c119465e03/6",
  "deckHref": "/decks/019de073-f021-770f-8b07-e7c119465e03",
  "deckJsonHref": "/decks/019de073-f021-770f-8b07-e7c119465e03.json",
  "deckAnchorHref": "/decks/019de073-f021-770f-8b07-e7c119465e03#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.485,
        "w": 0.425,
        "x": 0.529,
        "y": 0.269
      },
      "kind": "list",
      "text": "Delivered sequential sales improvement for Bausch Pharma and Solta this quarter\nReduced debt principal by $2.5B through very successful debt exchange offer\nContinue to evaluate potential options to maximize value\nVigorously defend our intellectual property in the Xifaxan® patent litigation",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "84574377-7dc6-4c28-9117-501c4b431c34",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.012,
        "w": 0.385,
        "x": 0.454,
        "y": 0.857
      },
      "kind": "source-note",
      "text": "1.See Slide 2 for further information on forward looking statements.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "13910d1a-62e4-4a19-9bc8-eda28a27c2b8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.128,
        "w": 0.336,
        "x": 0.04,
        "y": 0.414
      },
      "kind": "title",
      "text": "Key developments",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "91286689-d404-49f5-97a6-85d7054c6085",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "e4320b3c-17f3-4b5a-aea6-58b8be575f6e",
      "evidence": "list/bullet: Delivered sequential sales improvement for Bausch Pharma and Solta this quarter",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 8,
      "from": 5,
      "beatId": "88e9511c-ce40-4e8b-8dec-b440cd2df521",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The document highlights key actions underway and financial results to establish a need for change.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 24,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "05a42e5d-33da-405b-8ece-2b28299f64ad",
      "evidence": "The document implies that not taking action would result in missed opportunities and decreased financial performance.",
      "position": 0,
      "objective": "To highlight the cost of inaction and the benefits of the company's strategy",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}